FDA Approved: VIBERZI — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approves Allergan's supplemental application for VIBERZI (eluxadoline), expanding its regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Viberzi (eluxadoline)

Snippet

SUPPL AP for VIBERZI (ELUXADOLINE)